Chanussot B, Narce M, Poisson J P
Laboratoire de Physiologie Animale et de la Nutrition, Faculté des Sciences Mirande, Dijon, France.
Diabetologia. 1989 Nov;32(11):786-91. doi: 10.1007/BF00264908.
Rat liver microsomal delta 6 and delta 5 desaturation are defective in experimental diabetes, but this defect is correctable with insulin treatment. Rat liver fatty acid composition and delta 6 and delta 5 desaturation were studied in the spontaneously diabetic adult female Bio-Breeding (BB) rat. Control Wistar rats and BB rats (4 weeks of diabetes), that received insulin (1 IU.100 g body weight-1.day-1), were killed 20 h after the last insulin injection. delta 6 and delta 5 desaturase activities were estimated from the incubation of liver microsomes with (1-14C) 18:2, n-6 or (2-14C) 20:3, n-6, respectively, and the fatty acid composition of the liver and microsomal liver lipids were investigated. Under experimental conditions delta 6 and delta 5 desaturase activities were unchanged in the BB rats when compared to the control rats. Impairment of the liver fatty acid composition of diabetic BB rats is not consistent with normal desaturase activity and may be explained by factors other than desaturation disturbance.
在实验性糖尿病中,大鼠肝脏微粒体的Δ6和Δ5去饱和作用存在缺陷,但这种缺陷可通过胰岛素治疗得到纠正。我们对成年自发性糖尿病雌性Bio-Breeding(BB)大鼠的肝脏脂肪酸组成以及Δ6和Δ5去饱和作用进行了研究。在最后一次注射胰岛素20小时后,处死对照Wistar大鼠和接受胰岛素(1 IU·100 g体重-1·天-1)的BB大鼠(糖尿病4周)。分别通过肝脏微粒体与(1-14C)18:2,n-6或(2-14C)20:3,n-6孵育来估算Δ6和Δ5去饱和酶活性,并研究肝脏和微粒体肝脏脂质的脂肪酸组成。在实验条件下,与对照大鼠相比,BB大鼠的Δ6和Δ5去饱和酶活性没有变化。糖尿病BB大鼠肝脏脂肪酸组成的损害与正常去饱和酶活性不一致,可能是由去饱和紊乱以外的因素所解释。